This filing is routine executive compensation. No immediate trading signal. Monitor for clinical data readouts or pipeline updates, which are the primary value drivers for this clinical-stage biotech.
Price Chart
Executive Summary
Aura Biosciences granted inducement equity awards to new CEO Natalie Holles, consisting of stock options, RSUs, and performance-based RSUs. This is a standard compensation action following her previously disclosed appointment and does not represent a change in business fundamentals.
Key Facts
- Inducement awards granted to new CEO Natalie Holles on May 19, 2026.
- Includes options for 2,169,103 shares at $7.39, RSUs for 600,118 shares, and PRSUs for 553,844 shares.
- Awards are consistent with previously disclosed terms of her offer letter approved by the Board.
- No financial results, clinical data, or guidance changes included in the release.
Financial Impact
Undisclosed; inducement awards are standard compensation and do not represent cash outlay.
Risk Factors
- Potential dilution from equity awards if vested and exercised.
- No change in fundamental risks related to clinical development or regulatory approval.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3297997 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Institutional Cluster | $6.45 $6.56 | ▲ +1.71% | ▲ +2.27% | $6.16 (−4.50%) |
Aug 21, 2026 9w ago | EFFECT | $7.80 $6.36 | ▲ +18.46% | ▲ +17.94% | $6.16 (+21.03%) |
Aug 11, 2026 11w ago | 8-K | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.16 (+23.38%) |
Aug 11, 2026 11w ago | Press Release | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.16 (+23.38%) |
Jul 8, 2026 15w ago | 8-K | $7.25 $7.18 | ▼ −0.97% | ▼ −4.24% | $6.16 (−15.03%) |
May 19, 2026 22w ago | Press Release | $7.47 $6.34 | ▼ −15.13% | ▼ −15.87% | $6.16 (−17.54%) |
May 5, 2026 24w ago | 8-K | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.16 (+25.69%) |
May 5, 2026 24w ago | Press Release | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.16 (+25.69%) |
May 4, 2026 25w ago | 8-K | $8.90 $6.90 | ▼ −22.47% | ▼ −27.43% | $6.16 (−30.79%) |
May 4, 2026 25w ago | Press Release | $8.35 $7.19 | ▲ +13.89% | ▲ +19.54% | $6.16 (+26.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers